Beijing Wantai Biological Pharmacy Enterprise Co Ltd

603392

Company Profile

  • Business description

    Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in research, development, production, and sales of in vitro diagnostic reagents, instruments, and vaccines. The company has two segments: Diagnostic and Vaccine. The Diagnostic segment develops and sells in vitro diagnostic reagents such as ELISA, colloidal gold, biochemical, and chemiluminescent kits, along with instruments including chemiluminescent analyzers, fluorescent analyzers, and nucleic acid purification systems. The Vaccine segment focuses on products like the hepatitis E vaccine, the bivalent HPV vaccine, and the nasal spray COVID-19 vaccine. It generates the majority of its revenue from the Diagnostic segment.

  • Contact

    No. 31, Science Park Road
    Changping District
    Beijing102206
    CHN

    T: +86 1059528888

    https://www.ystwt.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    4,116

Stocks News & Analysis

stocks

ASX major bank drives strong quarterly profit

Profit momentum remains robust yet shares overvalued.
stocks

Ask the analyst: What to expect in earnings season?

The key metrics that matter this earnings season.
stocks

ASX healthcare share remains undervalued ahead of earnings

Margin recovery remains the key driver for this ASX healthcare share.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,063.8036.200.40%
CAC 408,406.0633.780.40%
DAX 4025,361.03262.031.04%
Dow JONES (US)52,210.08262.830.51%
FTSE 10010,781.7545.520.42%
HKSE25,207.18243.950.98%
NASDAQ24,932.0843.74-0.18%
Nikkei 22564,931.19320.040.50%
NZX 50 Index13,810.7039.99-0.29%
S&P 5007,413.181.200.02%
S&P/ASX 2008,894.0036.100.41%
SSE Composite Index3,858.2544.051.15%

Market Movers